Arrowpoint Life Science Fund, L.P. — Form D/A
Arrowpoint Life Science Fund, L.P. of DENVER, CO, a pooled investment fund, filed a Form D amendment with the SEC on 2014-08-14. $27.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2014-08-14
- Form: D/A
- Accession: 0001556383-14-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $27.0M
- Minimum investment: $1
- Investors: 8
- Date of first sale: 2012-09-04
- Security types: fund interests
- SEC file number: 021-182840
Issuer
- Name: Arrowpoint Life Science Fund, L.P.
- CIK: 0001556383
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 100 FILLMORE STREET, SUITE 325, DENVER, CO, 80206
- Phone: (303) 398-2929
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Corkins | Executive Officer | Denver, CO |
| Karen Reidy | Executive Officer | Denver, CO |
| Minyoung Sohn | Executive Officer | Denver, CO |
| David Corkins | Promoter | Denver, CO |
| Tony Yao | Executive Officer | Denver, CO |
Other filings by this issuer (2)
More